Navigation Links
Lilly Reports Third-Quarter 2011 Results
Date:10/20/2011

>"In the third quarter Lilly continued to drive revenue growth for many key brands, including Cymbalta, Humalog, Forteo and Strattera, with strong growth also seen in animal health, Japan and China. This growth offset the continued erosion of Gemzar sales due to generic competition," said John C. Lechleiter, Ph.D., Lilly's chairman, president and chief executive officer. "As we face the loss of patent exclusivity for Zyprexa in most major markets, we are well-prepared as a company to meet the challenges before us. We remain committed to our innovation-based strategy and are focused on delivering the next wave of new medicines to patients in the coming years."

Key Events Over the Last Three Months

  • The European Commission granted marketing authorization for Trajenta® for the treatment of adults with type 2 diabetes. The company and its partner Boehringer Ingelheim have recently begun launching Trajenta in the European Union, beginning with the United Kingdom.

  • The U.S. Food and Drug Administration (FDA) approved Cialis® tablets for once daily use for the treatment of men who have both erectile dysfunction and the signs and symptoms of benign prostatic hyperplasia (ED+BPH). The FDA also approved Cialis for once daily use for a separate indication for the treatment of the signs and symptoms of BPH.

  • The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion for the use of Alimta® as continuation maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer (NSCLC).

  • The U.S. Court of Appeals for the Federal Circuit overturned a prior ruling by the U.S. District Court for the District of New Jersey and upheld the validity of the company's method-of-use patent on Strattera®. The method-of-use patent provides protection for Strattera through May of 2017.

  • The company, along with its partners Amylin Pharmaceutic
    '/>"/>

  • SOURCE Eli Lilly and Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Lilly Declares Fourth-Quarter 2011 Dividend
    2. Lilly Announces Changes in Senior Management
    3. Lilly Confirms Date and Conference Call for Third-Quarter 2011 Financial Results Announcement
    4. Lilly Improves Its Environmental Footprint in Business Operations and Helps Beautify Communities
    5. Eli Lilly and Company Bringing Diabetes Education Program to the Annual Legislative Conference
    6. Lilly Celebrates 17th Consecutive Year as One of Working Mother 100 Best Companies
    7. Lilly Health Channel Debuts on YouTube
    8. Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
    9. The American Diabetes Association and Eli Lilly and Company Encourage African Americans to Learn About Diabetes Through a Familiar Face
    10. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
    11. U.S. Court of Appeals Affirms Validity of Lillys Strattera Patent
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/16/2015)... WASHINGTON , April 16, 2015 Vanda ... company focused on the development and commercialization of products ... announced it will release results for the first quarter ... market closes. The Company will host ... May 6, 2015, during which Vanda management will discuss ...
    (Date:4/16/2015)... , April 16, 2015 A drug commonly taken ... of people with multiple sclerosis (MS), according to a study ... of Neurology,s 67th Annual Meeting in Washington, DC ... "About half of people with MS experience at some point ... which the nerve carrying vision from the eye to the ...
    (Date:4/16/2015)... Calif. , April 16, 2015  Alexza Pharmaceuticals, Inc. ... quarter ended March 31, 2015 on Wednesday, May 6, 2015, ... will also host an investor conference call and live webcast ... provide a company update and discuss the financial results.  ... to www.alexza.com , under the "Investors" link.  Please log ...
    Breaking Medicine Technology:Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2Epilepsy Drug May Preserve Eyesight for People with MS 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 3
    (Date:4/19/2015)... 19, 2015 HealthPostures, LLC , a ... it will exhibit it’s pioneering ergonomics products at the ... Iowa-Illinois Safety Council Professional Development Conference and Expo . ... EZ are used in volume by call centers, educational ... Built to clamp to a desk, the TaskMate Go ...
    (Date:4/18/2015)... 2015 Carinsurancequotesinfo.com has released a new ... physical injuries caused by a car accident. ... for a vehicle. A policy can pay for car ... Drivers should always carry appropriate coverage when they are ... be bought with several important riders that offer extra ...
    (Date:4/18/2015)... April 18, 2015 "I wanted ... to create a healthful juice that contained essential ... Rosedale, Md. "It increases my energy, improves skin ... , He developed Tapp's Juice to contain fruits, ... to prevent physical and mental fatigue. It features ...
    (Date:4/18/2015)... (PRWEB) April 18, 2015 Lower-auto-insurance.com has ... accurate auto insurance quotes . , ... policies by comparing quotes. A professional insurance brokerage website ... insurance quotes, in a simple, convenient way. The whole ... to anyone. , Comparing online car insurance quotes ...
    (Date:4/18/2015)... More than 2000 styles of newly designed prom dresses ... store carrying celebrity inspired special occasion dresses. With the ... dresses for their prom. For those who are still ... would be an ideal choice. , "We have ... by the most loved styles seen at this years ...
    Breaking Medicine News(10 mins):Health News:HealthPostures' TaskMate Products to be Exhibited at the Wisconsin and Iowa-Illinois Safety Conferences 2Health News:Auto Insurance Plans Can Cover Physical Injuries Caused By An Accident! 2Health News:Auto Insurance Quotes Can Provide Accurate Results! 2Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2
    ... , ... ... ... ...
    ... , ... ... ... ...
    ... , ... ... ... , ...
    ... ... ... , ... , , ...
    ... Women aged 50 to 76 who take estrogen plus ... to a new study published in the pre-print online edition ... the risk is "duration-dependent," with women taking HRT for 10-plus ... length of HRT has yet to be determined, the researchers ...
    ... than commonly believed , WEDNESDAY, March 3 (HealthDay News) -- ... according to a new study that may trigger a major ... long been believed that glaucoma -- the leading cause of ... the eye that damages the retina and optic nerve, so ...
    Cached Medicine News:Health News:FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs 2Health News:FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs 3Health News:FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs 4Health News:FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs 5Health News:FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs 6Health News:Centene Corporation to Present at Cowen and Company Annual Health Care Conference 2Health News:Centene Corporation to Present at Cowen and Company Annual Health Care Conference 3Health News:Obama Proposes Health Care Bill Fully Funding Abortion 2Health News:Obama Proposes Health Care Bill Fully Funding Abortion 3Health News:89 Women Celebrate Mardi Gras with Mammograms 2Health News:89 Women Celebrate Mardi Gras with Mammograms 3Health News:Hormone replacement therapy linked to increased lung cancer risk 2Health News:Glaucoma Begins in Mid-Brain, Not in Eye, Research Shows 2
    Take Performance to a Higher Level....
    The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC)....
    FemoStop plus system is a femoral compression system for hemostasis management. It provides a comfortable and efficient "hands off method of compressing the femoral artery and vein after diagnostic ...
    ... used to seal the arterial puncture site. Duett ... the arteriotomy and the tissue tract with a ... a balloon catheter and procoagulant - the Duett ... stop the bleeding. The Duett is unique in ...
    Medicine Products: